Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
CNY 4.67
(-0.21%)
CNY 4.67
(-0.21%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -420.05 Million CNY | -577.26% |
| 2022 | 88.01 Million CNY | -7.58% |
| 2021 | 95.22 Million CNY | -70.21% |
| 2020 | 319.71 Million CNY | -58.52% |
| 2019 | 770.78 Million CNY | 27.4% |
| 2018 | 605 Million CNY | 76.79% |
| 2017 | 342.21 Million CNY | 52.08% |
| 2016 | 225.01 Million CNY | -56.44% |
| 2015 | 516.58 Million CNY | 865.24% |
| 2014 | 53.51 Million CNY | 165.18% |
| 2013 | -82.1 Million CNY | -460.43% |
| 2012 | 22.78 Million CNY | -78.32% |
| 2011 | 105.06 Million CNY | 22.7% |
| 2010 | 85.62 Million CNY | 182.59% |
| 2009 | 30.3 Million CNY | 18.38% |
| 2008 | 25.59 Million CNY | -17.56% |
| 2007 | 31.05 Million CNY | -40.42% |
| 2006 | 52.11 Million CNY | 5.07% |
| 2005 | 49.59 Million CNY | 41.16% |
| 2004 | 35.13 Million CNY | 56.7% |
| 2003 | 22.42 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 5.5 Million CNY | -83.1% |
| 2024 Q3 | -26.12 Million CNY | -574.17% |
| 2024 Q1 | 32.59 Million CNY | 108.54% |
| 2023 Q2 | -22.93 Million CNY | -154.46% |
| 2023 Q1 | 42.1 Million CNY | 135.13% |
| 2023 Q4 | -381.46 Million CNY | -560.44% |
| 2023 FY | -420.05 Million CNY | -577.26% |
| 2023 Q3 | -57.75 Million CNY | -151.9% |
| 2022 Q3 | 35.45 Million CNY | -58.11% |
| 2022 Q1 | 87.02 Million CNY | 368.66% |
| 2022 FY | 88.01 Million CNY | -7.58% |
| 2022 Q4 | -119.84 Million CNY | -438.02% |
| 2022 Q2 | 84.63 Million CNY | -2.74% |
| 2021 Q4 | 18.56 Million CNY | 14.95% |
| 2021 FY | 95.22 Million CNY | -70.21% |
| 2021 Q1 | 57.18 Million CNY | 235.48% |
| 2021 Q2 | 3.31 Million CNY | -94.2% |
| 2021 Q3 | 16.15 Million CNY | 386.75% |
| 2020 Q1 | 105.12 Million CNY | 30.28% |
| 2020 Q2 | 160.47 Million CNY | 52.66% |
| 2020 Q3 | 96.33 Million CNY | -39.97% |
| 2020 FY | 319.71 Million CNY | -58.52% |
| 2020 Q4 | -42.21 Million CNY | -143.82% |
| 2019 Q1 | 202.48 Million CNY | 65.99% |
| 2019 FY | 770.78 Million CNY | 27.4% |
| 2019 Q4 | 80.68 Million CNY | -58.47% |
| 2019 Q3 | 194.29 Million CNY | -33.76% |
| 2019 Q2 | 293.3 Million CNY | 44.85% |
| 2018 Q1 | 44.76 Million CNY | -21.41% |
| 2018 FY | 605 Million CNY | 76.79% |
| 2018 Q4 | 121.98 Million CNY | -41.12% |
| 2018 Q3 | 207.16 Million CNY | -10.35% |
| 2018 Q2 | 231.08 Million CNY | 416.18% |
| 2017 Q2 | 127.14 Million CNY | 9.32% |
| 2017 Q3 | 41.78 Million CNY | -67.13% |
| 2017 Q1 | 116.31 Million CNY | 155.61% |
| 2017 FY | 342.21 Million CNY | 52.08% |
| 2017 Q4 | 56.96 Million CNY | 36.32% |
| 2016 Q3 | 130.23 Million CNY | -23.85% |
| 2016 Q1 | 132.93 Million CNY | 101.5% |
| 2016 FY | 225.01 Million CNY | -56.44% |
| 2016 Q4 | -209.17 Million CNY | -260.61% |
| 2016 Q2 | 171.02 Million CNY | 28.65% |
| 2015 FY | 516.58 Million CNY | 865.24% |
| 2015 Q4 | 65.97 Million CNY | -44.43% |
| 2015 Q3 | 118.71 Million CNY | -30.6% |
| 2015 Q2 | 171.06 Million CNY | 6.36% |
| 2015 Q1 | 160.83 Million CNY | 251.83% |
| 2014 FY | 53.51 Million CNY | 165.18% |
| 2014 Q3 | 573.19 Thousand CNY | -85.19% |
| 2014 Q2 | 3.87 Million CNY | 15.19% |
| 2014 Q4 | 45.71 Million CNY | 7875.33% |
| 2014 Q1 | 3.36 Million CNY | 105.75% |
| 2013 Q1 | 3.15 Million CNY | 106.55% |
| 2013 Q2 | -681.58 Thousand CNY | -121.6% |
| 2013 Q3 | -26.1 Million CNY | -3729.31% |
| 2013 Q4 | -58.48 Million CNY | -124.06% |
| 2013 FY | -82.1 Million CNY | -460.43% |
| 2012 Q4 | -48.16 Million CNY | -2444.71% |
| 2012 Q3 | 2.05 Million CNY | -92.36% |
| 2012 FY | 22.78 Million CNY | -78.32% |
| 2012 Q1 | 41.98 Million CNY | 53.07% |
| 2012 Q2 | 26.9 Million CNY | -35.93% |
| 2011 FY | 105.06 Million CNY | 22.7% |
| 2011 Q4 | 27.43 Million CNY | 29.22% |
| 2011 Q3 | 21.22 Million CNY | -20.86% |
| 2011 Q2 | 26.82 Million CNY | -9.33% |
| 2011 Q1 | 29.58 Million CNY | 163.87% |
| 2010 Q1 | 17.7 Million CNY | 63.73% |
| 2010 Q3 | 27.65 Million CNY | -4.87% |
| 2010 Q2 | 29.06 Million CNY | 64.21% |
| 2010 FY | 85.62 Million CNY | 182.59% |
| 2010 Q4 | 11.21 Million CNY | -59.46% |
| 2009 FY | 30.3 Million CNY | 18.38% |
| 2009 Q4 | 10.81 Million CNY | 92.79% |
| 2009 Q3 | 5.6 Million CNY | -43.45% |
| 2009 Q2 | 9.91 Million CNY | 149.96% |
| 2009 Q1 | 3.96 Million CNY | 312.75% |
| 2008 Q1 | 11.86 Million CNY | 1328.08% |
| 2008 Q2 | 13.17 Million CNY | 11.08% |
| 2008 Q3 | 2.41 Million CNY | -81.65% |
| 2008 Q4 | -1.86 Million CNY | -177.12% |
| 2008 FY | 25.59 Million CNY | -17.56% |
| 2007 Q2 | 11.13 Million CNY | -1.07% |
| 2007 FY | 31.05 Million CNY | -40.42% |
| 2007 Q4 | -966.12 Thousand CNY | -110.03% |
| 2007 Q3 | 9.63 Million CNY | -13.44% |
| 2007 Q1 | 11.25 Million CNY | 11.83% |
| 2006 Q3 | 13.45 Million CNY | -19.45% |
| 2006 Q4 | 10.06 Million CNY | -25.23% |
| 2006 FY | 52.11 Million CNY | 5.07% |
| 2006 Q2 | 16.7 Million CNY | 36.55% |
| 2006 Q1 | 12.23 Million CNY | -5.48% |
| 2005 FY | 49.59 Million CNY | 41.16% |
| 2005 Q3 | 13.57 Million CNY | 0.0% |
| 2005 Q4 | 12.94 Million CNY | -4.63% |
| 2004 FY | 35.13 Million CNY | 56.7% |
| 2003 FY | 22.42 Million CNY | 0.0% |